Andrew Macadam

3.1k citations

43 papers · 1.8k indexed · h-index 24

Impact in

Infectious Diseases top 1%
- Viral gastroenteritis research and epidemiology
- SARS-CoV-2 and COVID-19 Research
Cardiology and Cardiovascular Medicine top 1%
- Viral Infections and Immunology Research

Papers in

Cardiology and Cardiovascular Medicine 42
- Viral Infections and Immunology Research 42
Infectious Diseases 33
- Viral gastroenteritis research and epidemiology 33

Co-authors: Philip D. Minor Jeffrey W. Almond G. Ferguson James M. Hogle R. Syed M Chow David J. Filman David M. Stone
Journals: Journal of Virology (7 papers)npj Vaccines (4 papers)Virology (4 papers)Biologicals (2 papers)PLoS Pathogens (2 papers)
Partner nations: United Kingdom United States France

In The Last Decade

Andrew Macadam

40 papers receiving 1.8k citations

Peers

Countries citing papers authored by Andrew Macadam

Since Specialization

Citations

This map shows the geographic impact of Andrew Macadam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Macadam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Macadam more than expected).

Fields of papers citing papers by Andrew Macadam

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Macadam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Macadam. The network helps show where Andrew Macadam may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Andrew Macadam, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Andrew Macadam Line = papers co-authored together Andrew Macadam links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Production of an immunogenic trivalent poliovirus virus-like particle vaccine candidate in yeast using controlled fermentation npj Vaccines ·Lee Sherry, Keith Grehan, Mohammad W. Bahar, Raghu M. Reddy, Helen Fox, Sue Matthews, Kentaro sugimoto, S. M. Mironova, Claudine Porta, Steven Wilkinson, Petra Recio San Emeterio, Nathaniel E. Clark, John Liddell, Elizabeth E. Fry, David I. Stuart, Andrew Macadam, David J. Rowlands, Nicola J. Stonehouse	2025	0
2	Non-lytic spread of poliovirus requires the nonstructural protein 3CD mBio ·D. C., Stefan Särdqvist, Xinni Yang, Victoria Korboukh, 雄史斎藤, Jennifer L. Gray, Neela H. Yennawar, Ibrahim M. Moustafa, Andrew Macadam, Craig E. Cameron	2024	0
3	Production of antigenically stable enterovirus A71 virus-like particles in Pichia pastoris as a vaccine candidate Journal of General Virology ·R. Hegnauer, Catherine Ringham, Agnieszka Martyna, Chun Ping Chang, Keith Grehan, Connor Knight, Allen W Hinderaker, Helen Fox, Andrew Macadam, Javier Martín, James M. Hogle, David J. Rowlands, Nicola J. Stonehouse	2023	9
4	A conserved glutathione binding site in poliovirus is a target for antivirals and vaccine stabilisation Communications Biology ·Mohammad W. Bahar, Veronica Nasta, Helen Fox, Lee Sherry, Keith Grehan, Claudine Porta, Andrew Macadam, Nicola J. Stonehouse, David J. Rowlands, Elizabeth E. Fry, David I. Stuart	2022	5
5	Generated Randomly and Selected Functionally? The Nature of Enterovirus Recombination Viruses ·Fadi G. Alnaji, Kirsten Bentley, 涂云华, Andrew Woodman, Jonathan D. Moore, Helen Fox, Andrew Macadam, David J. Evans	2022	7
6	Genetic and phenotypic stability of poliovirus shed from infants who received novel type 2 or Sabin type 2 oral poliovirus vaccines in Panama: an analysis of two clinical trials The Lancet Microbe ·Rahnuma Wahid, Laina D. Mercer, F. Na, Rodrigo DeAntonio, Xavier Sáez‐Llorens, Andrew Macadam, Konstantin Chumakov, Jeroen R. P. M. Strating, Björn F. Koel, Jennifer L. Konopka‐Anstadt, M. Steven Oberste, Cara C. Burns, Raul Andino, S. Yamdagni, Ananda S Bandyopadhyay, Anugerah Chandra Lasmana, Ricardo Rüttimann, Chris Gast, John Konz	2022	10
7	Mammalian expression of virus-like particles as a proof of principle for next generation polio vaccines npj Vaccines ·Mohammad W. Bahar, Claudine Porta, Helen Fox, Andrew Macadam, Elizabeth E. Fry, David I. Stuart	2021	28
8	Engineering the Live-Attenuated Polio Vaccine to Prevent Reversion to Virulence Cell Host & Microbe ·Ming Te Yeh, Erika Bujáki, Patrick Dolan, Matthew D. Smith, Rahnuma Wahid, John Konz, Amy J. Weiner, Ananda S Bandyopadhyay, Pierre Van Damme, Ilse De Coster, Hilde Revets, Andrew Macadam, Raul Andino	2020	136
9	Continued use of poliovirus after eradication: hyper‐attenuated strains as a safe alternative for release testing of human immunoglobulins Transfusion ·Maria R. Farcet, Jens Modrof, Josephine McCord, Andreas Schirmer, Andrew Macadam, Helen Fox, Philip D. Minor, Thomas R. Kreil	2018	5
10	Pathogenic Events in a Nonhuman Primate Model of Oral Poliovirus Infection Leading to Paralytic Poliomyelitis Journal of Virology ·Ling Shen, Crystal Y. Chen, Dan Huang, Richard Wang, Meihong Zhang, 吉輝青柳, 山本淳二, W. E. Stone, Enzhuo Yang, Arwa Qaqish, Konstantin Chumakov, Diana Kouiavskaia, Marco Vignuzzi, Neal Nathanson, Andrew Macadam, Raul Andino, Olen M. Kew, Jun‐Fa Xu, Zheng W. Chen	2017	29
11	Plant-made polio type 3 stabilized VLPs—a candidate synthetic polio vaccine Nature Communications ·Johanna Marsian, Helen Fox, Mohammad W. Bahar, Abhay Kotecha, Elizabeth E. Fry, David I. Stuart, Andrew Macadam, David J. Rowlands, George P. Lomonossoff	2017	87
12	Genetically Thermo-Stabilised, Immunogenic Poliovirus Empty Capsids; a Strategy for Non-replicating Vaccines PLoS Pathogens ·Helen Fox, Yunkai Xian, Philip D. Minor, Andrew Macadam	2017	39
13	Production of high titer attenuated poliovirus strains on the serum-free PER.C6® cell culture platform for the generation of safe and affordable next generation IPV Vaccine ·Kang Wenying, Gao YuanXue, Xiaoyu Cao, Ying Liu, Wilfred E. Marissen, Philip D. Minor, Eckard Wimmer, Hanneke Schuitemaker, Jerome Custers, Andrew Macadam, Jerónimo Cello, Diana Edo-Matas	2015	15
14	Functional Formation of Domain V of the Poliovirus Noncoding Region: Significance of Unpaired Bases Virology ·L. N. Yurtsev, Raseel Alsakran, Andrew Macadam, P. D. Minor	2001	3
15	Laboratory Tests for Live Attenuated Poliovirus Vaccines Biologicals ·David J. Wood, Andrew Macadam	1997	22
16	Poliovirus-specific CD4+ Th1 clones with both cytotoxic and helper activity mediate protective humoral immunity against a lethal poliovirus infection in transgenic mice expressing the human poliovirus receptor. The Journal of Experimental Medicine ·Bernard P. Mahon, Kersi Katrak, Akio Nomoto, Andrew Macadam, P. D. Minor, Kingston H. G. Mills	1995	93
17	Genetic Basis of Attenuation of the Sabin Type 2 Vaccine Strain of Poliovirus in Primates Virology ·Andrew Macadam, Stuart Pollard, G. Ferguson, Nasim Rostamkhani, David Wood, J. W. Almond, P. D. Minor	1993	109
18	Genetic Basis of Attenuation of the Sabin Oral Poliovirus Vaccines Biologicals ·Philip D. Minor, Andrew Macadam, David M. Stone, Jeffrey W. Almond	1993	45
19	Correlation of RNA secondary structure and attenuation of Sabin vaccine strains of poliovirus in tissue culture Virology ·Andrew Macadam, G. Ferguson, Raseel Alsakran, David M. Stone, Robin Skuce, Jeffrey W. Almond, Philip D. Minor	1992	61
20	Reversion of the attenuated and temperature-sensitive phenotypes of the sabin type 3 strain of poliovirus in vaccinees Virology ·Andrew Macadam, Caroline Arnold, A.D. Green, A. John, S.A. Marsden, F. Taffs, P. Reeve, Nobuyuki Hamada, 岡田雅史, J. W. Almond, N. Cammack, Philip D. Minor	1989	93

About Andrew Macadam

Andrew Macadam is a scholar working on Cardiology and Cardiovascular Medicine, Infectious Diseases, Animal Science and Zoology, Agronomy and Crop Science and Epidemiology, having authored 43 papers that have together received 1.8k indexed citations. Recurring topics across this work include Viral Infections and Immunology Research (42 papers), Viral gastroenteritis research and epidemiology (33 papers), Plant Virus Research Studies (8 papers), RNA and protein synthesis mechanisms (8 papers), Animal Virus Infections Studies (6 papers), Virus-based gene therapy research (5 papers), Viral Infectious Diseases and Gene Expression in Insects (5 papers) and Respiratory viral infections research (4 papers). The work is most often cited by research in Infectious Diseases (1.2k citations), Cardiology and Cardiovascular Medicine (1.4k citations), Animal Science and Zoology (254 citations), Agronomy and Crop Science (210 citations) and Gastroenterology (53 citations). Andrew Macadam has collaborated with scholars based in United Kingdom, United States and France. Frequent co-authors include Philip D. Minor, Jeffrey W. Almond, G. Ferguson, James M. Hogle, R. Syed, M Chow, David J. Filman, David M. Stone, Helen Fox and Raul Andino. Their work appears in journals such as Journal of Virology, npj Vaccines, Virology, Biologicals and PLoS Pathogens.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact